BYRN Stock Analysis: Byrna Technologies | NASDAQ

Aerospace & Defense | NASDAQ, USA | Market Cap: 140m USD | 12M Return: -87.8% | Charts, Fundamentals & Technical Analysis

Launchers, Projectiles, Irritant Sprays, Safety Accessories
Total Rating 20
Safety 38
Buy Signal -1.30
Aerospace & Defense
Industry Rotation: -4.4
Market Cap: 140M
Avg Turnover: 3.00M
Risk 3d forecast
Volatility231%
VaR 5th Pctl35.8%
VaR vs Median-5.25%
Reward TTM
Sharpe Ratio-2.16
Rel. Str. IBD0.1
Rel. Str. Peer Group0.5
Character TTM
Beta0.831
Beta Downside0.569
Hurst Exponent0.360
Drawdowns 3y
Max DD88.48%
CAGR/Max DD0.05
CAGR/Mean DD0.14
EPS (Earnings per Share) EPS (Earnings per Share) of BYRN over the last years for every Quarter: "2021-05": 0.16, "2021-08": -0.04, "2021-11": -0.06, "2022-02": -0.07, "2022-05": -0.05, "2022-08": -0.01, "2022-11": 0.06, "2023-02": -0.02, "2023-05": 0.04, "2023-08": -0.12, "2023-11": -0.04, "2024-02": 0.05, "2024-05": 0.12, "2024-08": 0.04, "2024-11": 0.4443, "2025-02": 0.1061, "2025-05": 0.1, "2025-08": 0.09, "2025-11": 0.14, "2026-02": 0.07,
Last SUE: -0.28
Qual. Beats: 0
Revenue Revenue of BYRN over the last years for every Quarter: 2021-05: 13.401, 2021-08: 8.703, 2021-11: 11.163, 2022-02: 7.977, 2022-05: 11.619, 2022-08: 12.422, 2022-11: 16.018, 2023-02: 8.411, 2023-05: 11.508, 2023-08: 7.085, 2023-11: 15.64, 2024-02: 16.654, 2024-05: 20.269, 2024-08: 20.854, 2024-11: 27.979, 2025-02: 26.19, 2025-05: 28.505, 2025-08: 28.179, 2025-11: 35.246, 2026-02: 29.049,
Rev. CAGR: 54.22%
Rev. Trend: 96.9%
Last SUE: -0.39
Qual. Beats: 0

Warnings

Earnings Expected To Drop (P/E To P/E Forward)
Beneish M-Score Likely Earnings Manipulation
Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.5 years of data

Jan +0.0% 0
Feb +0.4% 10
Mar -8.9% 11
Apr +0.0% 0
May +11.9% 9
Jun -1.4% 5
Jul -1.5% 2
Aug +1.3% 5
Sep +0.0% 0
Oct -3.4% 2
Nov +0.0% 0
Dec -0.5% 2

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: BYRN Byrna Technologies

Byrna Technologies Inc. (BYRN) specializes in the development and manufacture of non-lethal personal security solutions, including handheld and shoulder-fired launchers. Headquartered in Andover, Massachusetts, the company serves both consumer and professional security markets across North America, South Africa, Europe, and Asia. Its product ecosystem includes chemical irritant projectiles, kinetic rounds, and integrated safety accessories like body armor and aerosol repellents.

The company operates within the specialized defense technology sector, focusing on products that generally do not require a firearms license or background check for purchase. This business model leverages a multi-channel distribution strategy, utilizing direct-to-consumer e-commerce platforms alongside a network of outdoor and sporting goods retailers. By targeting the less-lethal niche, the company addresses a growing market for self-defense tools that occupy the space between traditional firearms and passive security measures.

For more detailed financial analysis and historical performance metrics, consider reviewing the comprehensive data available on ValueRay.

Headlines to Watch Out For
  • Direct-to-consumer marketing success drives record e-commerce revenue and customer acquisition
  • Celebrity endorsements and media appearances trigger immediate spikes in hardware sales
  • Regulatory shifts in firearm laws increase demand for less-lethal alternatives
  • Expansion into big-box retail and international markets diversifies global revenue streams
  • Production scalability and supply chain efficiency determine gross margin performance
Piotroski VR-10 (Strict) 4.0
Net Income: 8.83m TTM > 0 and > 6% of Revenue
FCF/TA: -0.10 > 0.02 and ΔFCF/TA -8.67 > 1.0
NWC/Revenue: 39.16% < 20% (prev 38.38%; Δ 0.78% < -1%)
CFO/TA -0.03 > 3% & CFO -2.22m > Net Income 8.83m
Net Debt (-7.04m) to EBITDA (13.0m): -0.54 < 3
Current Ratio: 4.96 > 1.5 & < 3
Outstanding Shares: last quarter (23.8m) vs 12m ago -1.12% < -2%
Gross Margin: 60.30% > 18% (prev 61.97%; Δ -1.68% > 0.5%)
Asset Turnover: 160.3% > 50% (prev 134.1%; Δ 26.16% > 0%)
Interest Coverage Ratio: error (cannot be calculated; needs correct EBIT TTM and Interest Expense TTM)
Altman Z'' 8.16
A: 0.59 (Total Current Assets 59.3m - Total Current Liabilities 12.0m) / Total Assets 79.9m
B: -0.58 (Retained Earnings -46.3m / Total Assets 79.9m)
C: 0.14 (EBIT TTM 10.7m / Avg Total Assets 75.5m)
D: 4.96 (Book Value of Equity 66.5m / Total Liabilities 13.4m)
Altman-Z'' = 8.16 = AAA
Beneish M -1.23
DSRI: 3.0 (Receivables 11.6m/2.90m, Revenue 121.0m/95.3m)
GMI: 1.03 (GM 61.97% / 60.30%)
AQI: 0.86 (AQ_t 0.14 / AQ_t-1 0.16)
SGI: 1.27 (Revenue 121.0m / 95.3m)
TATA: 0.14 (NI 8.83m - CFO -2.22m) / TA 79.9m)
Beneish M = -1.23 (Cap -4..+1) = D
What is the price of BYRN shares?

As of July 10, 2026, the stock is trading at USD 3.94 with a total of 5,202,715 shares traded. Over the past week, the price has changed by -42.06%, over one month by -36.96%, over three months by -37.95% and over the past year by -87.80%.

Current recommended Stop Loss: 3.30 (which is 16.2% or 1.3 ATR below the current price).

Is BYRN a buy, sell or hold?

Byrna Technologies has received a consensus analysts rating of 4.75. Therefore, it is recommended to buy BYRN.

  • StrongBuy: 3
  • Buy: 1
  • Hold: 0
  • Sell: 0
  • StrongSell: 0

What are the forecasts/targets for the BYRN price?
Analysts Target Price 13.7 247%
Byrna Technologies (BYRN) - Fundamental Data Overview as of 10 July 2026
Market Cap USD = 139.5m (139.5m USD * 1.0 USD.USD)
P/E Trailing = 19.8387
P/E Forward = 40.9836
P/S = 1.1532
P/B = 2.3782
Revenue TTM = 121.0m USD
EBIT TTM = 10.7m USD
EBITDA TTM = 13.0m USD
Long Term Debt = 1.42m USD (estimated: total debt 2.17m - short term 751k)
Short Term Debt = 751k USD (from shortTermDebt, last quarter)
Debt = 2.17m USD (from shortLongTermDebtTotal, last quarter) (leases 2.17m already included)
Net Debt = -7.04m USD (calculated: Debt 2.17m - CCE 9.21m)
Enterprise Value = 132.5m USD (139.5m + Debt 2.17m - CCE 9.21m)
 Interest Coverage Ratio = unknown (Ebit TTM 10.7m / Interest Expense TTM 0.0)
 EV/FCF = -16.94x (Enterprise Value 132.5m / FCF TTM -7.82m)
FCF Yield = -5.90% (FCF TTM -7.82m / Enterprise Value 132.5m)
FCF Margin = -6.46% (FCF TTM -7.82m / Revenue TTM 121.0m)
Net Margin = 7.30% (Net Income TTM 8.83m / Revenue TTM 121.0m)
Gross Margin = 60.30% ((Revenue TTM 121.0m - Cost of Revenue TTM 48.0m) / Revenue TTM)
Gross Margin QoQ = 59.90% (prev 59.75%)
Tobins Q-Ratio = 1.66 (Enterprise Value 132.5m / Total Assets 79.9m)
Interest Expense / Debt = 0.0% (Interest Expense 0.0 / Debt 2.17m)
Taxrate = 17.79% (1.91m / 10.7m)
NOPAT = 8.83m (EBIT 10.7m * (1 - 17.79%))
Current Ratio = 4.96 (Total Current Assets 59.3m / Total Current Liabilities 12.0m)
Debt / Equity = 0.03 (Debt 2.17m / totalStockholderEquity, last quarter 66.5m)
Debt / EBITDA = -0.54 (Net Debt -7.04m / EBITDA 13.0m)
 Debt / FCF = 0.90 (negative FCF - burning cash) (Net Debt -7.04m / FCF TTM -7.82m)
 Total Stockholder Equity = 63.9m (last 4 quarters mean from totalStockholderEquity)
RoA = 11.70% (Net Income 8.83m / Total Assets 79.9m)
RoE = 13.82% (Net Income TTM 8.83m / Total Stockholder Equity 63.9m)
RoCE = 16.44% (EBIT 10.7m / Capital Employed (Equity 63.9m + L.T.Debt 1.42m))
RoIC = 14.09% (NOPAT 8.83m / Invested Capital 62.6m)
WACC = 8.76% (E(139.5m)/V(141.7m) * Re(8.90%) + D(2.17m)/V(141.7m) * Rd(0.0%) * (1-Tc(0.18)))
Discount Rate = 8.90% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 64.44 | Cagr: 3.63%
 [DCF] Fair Price = unknown (Cash Flow -7.82m)
 EPS Correlation: N/A | EPS CAGR: N/A | SUE: -0.28 | # QB: 0
Revenue Correlation: 96.87 | Revenue CAGR: 54.22% | SUE: -0.39 | # QB: 0
EPS current Quarter (2026-05-31): EPS=-0.12 | Chg30d=-220.00% | Revisions=-25% | Analysts=1
EPS next Quarter (2026-08-31): EPS=-0.11 | Chg30d=-210.00% | Revisions=-25% | Analysts=1
EPS current Year (2026-11-30): EPS=-0.11 | Chg30d=-126.83% | Revisions=-25% | GrowthEPS=-121.3% | GrowthRev=-4.0%
EPS next Year (2027-11-30): EPS=0.06 | Chg30d=-89.29% | Revisions=-25% | GrowthEPS=+154.6% | GrowthRev=+10.6%